Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 14, 2024

SELL
$36.71 - $44.15 $9.07 Million - $10.9 Million
-247,193 Reduced 20.46%
961,190 $40 Million
Q2 2023

Aug 14, 2023

SELL
$36.71 - $44.15 $9.07 Million - $10.9 Million
-247,193 Reduced 20.46%
961,190 $40 Million
Q1 2023

May 14, 2024

BUY
$36.81 - $48.12 $17.1 Million - $22.3 Million
463,286 Added 62.18%
1,208,383 $49.9 Million
Q1 2023

May 11, 2023

BUY
$36.81 - $48.12 $17.1 Million - $22.3 Million
463,286 Added 62.18%
1,208,383 $49.9 Million
Q4 2022

May 14, 2024

BUY
$35.68 - $44.71 $3.83 Million - $4.8 Million
107,423 Added 16.85%
745,097 $30.7 Million
Q4 2022

Feb 13, 2023

BUY
$35.68 - $44.71 $3.83 Million - $4.8 Million
107,423 Added 16.85%
745,097 $30.7 Million
Q3 2022

May 14, 2024

BUY
$42.51 - $54.02 $3.18 Million - $4.04 Million
74,785 Added 13.29%
637,674 $27.9 Million
Q3 2022

Nov 10, 2022

BUY
$42.51 - $54.02 $3.18 Million - $4.04 Million
74,785 Added 13.29%
637,674 $27.9 Million
Q2 2022

May 14, 2024

BUY
$46.84 - $59.75 $26.4 Million - $33.6 Million
562,889 New
562,889 $27.7 Million
Q2 2022

Aug 15, 2022

SELL
$46.84 - $59.75 $22.8 Million - $29.1 Million
-486,657 Reduced 46.37%
562,889 $27.7 Million
Q1 2022

May 16, 2022

BUY
$48.09 - $57.79 $9.25 Million - $11.1 Million
192,295 Added 22.43%
1,049,546 $59.5 Million
Q4 2021

Feb 14, 2022

SELL
$47.19 - $62.68 $2.9 Million - $3.85 Million
-61,370 Reduced 6.68%
857,251 $45 Million
Q3 2021

Nov 10, 2021

BUY
$56.91 - $67.81 $52.3 Million - $62.3 Million
918,621 New
918,621 $55 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.